- Home
- TNYA vs INCR Comparison
TNYA vs INCR Comparison
Compare TNYA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- INCR
- Stock Information
- Founded
- TNYA 2016
- INCR 1994
- Country
- TNYA United States
- INCR Israel
- Employees
- TNYA N/A
- INCR N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- TNYA Health Care
- INCR Health Care
- Exchange
- TNYA Nasdaq
- INCR Nasdaq
- Market Cap
- TNYA 73.8M
- INCR 84.5M
- IPO Year
- TNYA 2021
- INCR N/A
- Fundamental
- Price
- TNYA $0.60
- INCR $1.48
- Analyst Decision
- TNYA Strong Buy
- INCR
- Analyst Count
- TNYA 5
- INCR 0
- Target Price
- TNYA $8.60
- INCR N/A
- AVG Volume (30 Days)
- TNYA 3.0M
- INCR 15.6K
- Earning Date
- TNYA 08-07-2025
- INCR 08-15-2025
- Dividend Yield
- TNYA N/A
- INCR N/A
- EPS Growth
- TNYA N/A
- INCR N/A
- EPS
- TNYA N/A
- INCR N/A
- Revenue
- TNYA N/A
- INCR $65,575,323.00
- Revenue This Year
- TNYA N/A
- INCR $69.54
- Revenue Next Year
- TNYA N/A
- INCR $41.75
- P/E Ratio
- TNYA N/A
- INCR N/A
- Revenue Growth
- TNYA N/A
- INCR N/A
- 52 Week Low
- TNYA $0.36
- INCR $1.17
- 52 Week High
- TNYA $4.06
- INCR $2.62
- Technical
- Relative Strength Index (RSI)
- TNYA 52.95
- INCR 44.04
- Support Level
- TNYA $0.54
- INCR $1.43
- Resistance Level
- TNYA $0.70
- INCR $1.50
- Average True Range (ATR)
- TNYA 0.06
- INCR 0.06
- MACD
- TNYA -0.00
- INCR -0.00
- Stochastic Oscillator
- TNYA 40.74
- INCR 30.77
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.